| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |